Clinical Trial Update: Danlou Tablets to Prevent Left Ventricular Remodeling [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Danlou Tablets to prevent left ventricular remodeling following acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Remodeling
• Myocardial Infarction

Drugs mentioned

• Danlou Tablets

Snippet

Sponsor: shuai Mao | Conditions: Left Ventricular Remodeling, Acute Myocardial Infarction | Phase 4 | Status: COMPLETED